Table 11.
Patient groups | Heart rate (beats/minute)
|
|||||||
---|---|---|---|---|---|---|---|---|
TPH gel
|
FPH gel
|
|||||||
Before application | After application | Percent decrease (%) | P-value | Before application | After application | Percent decrease (%) | P-value | |
Normal patient | 87±12.86 | 75±3.06 | 13 | Not significant | 75±3 | 71±6.11 | 5 | Not significant |
Hypertensive patient | 82±13.8 | 69±15.59 | 15.5 | Not significant | 89±3.61 | 75±5 | 16 | Not significant |
Diabetic patient | 107±0.71 | 94±2.12 | 12 | Not significant | 100±5 | 89±3.61 | 11 | Not significant |
Note: The values were the means ± standard deviation from three parallel measurements.
Abbreviations: TPH, transferosomal papaverine hydrochloride; FPH, free papaverine hydrochloride.